jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

June. 05, 2015

Dec. 17, 2018

jRCT2080222876

Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge Chamber

version:
date:

Shionogi & Co., Ltd.

http://www.shionogi.co.jp/information/inquiry_entrance.html

Interventional

Single-center, randomized, double-blind, placebo-controlled, parallel-group

2

Allergy test-positive patients who experienced symptoms of Japanese cedar pollinosis in the last two years or more.

Patients who potentially have allergic rhinitis, conjunctivitis or asthma caused by any allergens except for Japanese cedar pollen antigens.

12age old over
49age old under

Both

Japanese cedar pollinosis

investigational material(s)
Generic name etc : S-525606
INN of investigational material :
Therapeutic category code : 449 Other antiallergic agents
Dosage and Administration for Investigational material : Sublingual

Efficacy, safety

Shionogi & Co., Ltd.

JapicCTI-152928

History of Changes

No Publication date
7 Dec. 17, 2018 (this page) Changes
6 Mar. 31, 2016 Detail Changes
5 Mar. 31, 2016 Detail Changes
4 Sept. 30, 2015 Detail Changes
3 Sept. 30, 2015 Detail Changes
2 June. 05, 2015 Detail Changes
1 June. 05, 2015 Detail